• 1
    Ishihara, T., Nakamura, S., Kaziro, Y., Takahashi, T., Takahashi, K. & Nagata, S. (1991) Molecular cloning and expression of a cDNA encoding the secretin receptor, EMBO J. 10, 16351641.
  • 2
    Pisegna, J. R. & Wank, S. A. (1993) Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor, Proc. Natl Acad. Sci. USA 90, 63456349.
  • 3
    Svoboda, M., Tastenoy, M., Ciccarelli, E., Stiévenart, M. & Christophe, J. (1993) Cloning of a splice variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor, Biochem. Biophys. Res. Commun. 195, 881888.
  • 4
    Spengler, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburg, P. H. & Journot, L. (1993) Differential signal transduction by five splice variants of the PACAP receptor, Nature 365, 170175.
  • 5
    Ishihara, T., Shigemoto, R., Mori, K., Takahashi, K. & Nagata, S. (1992) Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide, Neuron 8, 811819.
  • 6
    Lutz, E. M., Sheward, W. J., West, K. M., Morrow, J. A., Fink, G. & Harmar, A. J. (1993) The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide, FEBS Lett. 334, 38.
  • 7
    Svoboda, M., Tastenoy, M., Van Rampelbergh, J., Goossens, J.-F., De Neef, P., Waelbroeck, M. & Robberecht, P. (1994) Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts, Biochem. Biophys. Res. Commun. 205, 16171624.
  • 8
    Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F. Jr, Lodish, H. F. & Goldring, S. R. (1991) Expression cloning of an adenylate cyclase-coupled calcitonin receptor, Science 254, 10221024.
  • 9
    Jüppner, H., Abou-Samra, A.-B., Freeman, M., Kong, X. F., Schipani, E., Richards, J., Kolakowski, L. F. Jr, Hock, J., Potts, J. T. Jr, Kronenberg, H. M. & Segre, G. V. (1991) A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide, Science 254, 10241026.
  • 10
    Mayo, K. E. (1992) Molecular cloning and expression for pituitary-specific receptor for growth hormone-releasing hormone, Mol. Endocrinol. 6, 17371744.
  • 11
    Jelinek, L. J., Lok, S., Rosenberg, G. B., Smith, R. A., Grant, F. J., Biggs, S., Bensch, P. A., Kuijper, J. L., Sheppard, P. O., Sprecher, C. A., O'Hara, P. J., Foster, D., Walker, K. M., Chen, L. H. J., McKernan, P. A. & Kindsvogel, W. (1993) Expression cloning and signaling properties of the rat glucagon receptor, Science 259, 16141616.
  • 12
    Svoboda, M., Ciccarelli, E., Tastenoy, M., Robberecht, P. & Christophe, J. (1993) A cDNA construct allowing the expression of rat hepatic glucagon receptors, Biochem. Biophys. Res. Commun. 192, 135142.
  • 13
    Thorens, B. (1992) Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide 1, Proc. Natl Acad. Sci. USA 89, 86418645.
  • 14
    Usdin, T. B., Mezey, E., Button, D. C., Brownstein, M. J. & Bonner, T. I. (1993) Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain, Endocrinology 133, 28612870.
  • 15
    Vilardaga, J.-P, De Neef, P., Di Paolo, E., Bollen, A., Waelbroeck, M. & Robberecht, P. (1995) Properties of chimeric and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination, Biochem. Biophys. Res. Commun. 211, 885891.
  • 16
    Holtmann, M. H., Hadac, E. M. & Miller, L. J. (1995) Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors, J. Biol. Chem. 270, 1439414398.
  • 17
    Vilardaga, J. P., Di Paolo, E., De Neef, P., Waelbroeck, M., Bollen, A. & Robberecht, P. (1996) Lysine 173 residue within the first exoloop of rat secretin receptor is involved in carboxylate moiety recognition of ASP 3 in secretin, Biochem. Biophys. Res. Commun. 218, 842846.
  • 18
    Vilardaga, J. P., Ciccarelli, E., Dubeaux, C., De Neef, P., Bollen, A. & Robberecht, P. (1994) Properties and regulation of the coupling to adenylate cyclase of the secretin receptor stably transfected in CHO cells, Mol. Pharmacol. 45, 10221028.
  • 19
    Young, D., Waitches, G., Birchmeier, C., Fasano, O. & Wigler, M. (1986) Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains, Cell 45, 711719.
  • 20
    Gerard, C. M., Mollereau, C., Vassart, G. & Parmentier, M. (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis, Biochem. J. 279, 129134.
  • 21
    Vilardaga, J.-P, Di Paolo, E. & Bollen, A. (1995) Improved PCR method for high-efficiency site-directed mutagenesis using class 2S restriction enzymes, Biotechniques 18, 605606.
  • 22
    Gaudin, P., Couvineau, A., Maoret, J.-J., Rouyer-Fessard, C. & Laburthe, M. (1995) Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding, Biochem. Biophys. Res. Commun. 211, 901908.
  • 23
    Karnik, S. S., Sakmar, T. P., Chen, H.-B. & Khorana, H. G. (1988) Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin, Proc. Natl Acad. Sci. USA 85, 84598463.
  • 24
    Furuhashi, M., Ando, H., Bielinska, M., Pixley, M. R., Shikone, T., Hsueh, A. J. W. & Boime, I. (1994) Mutagenesis of cysteine residues in the human gonadotropin α subunit, J. Biol. Chem. 269, 2554325548.
  • 25
    Davidson, F. F., Loewen, P. C. & Khorana, H. G. (1994) Structure and function in rhodopsin: Replacement by alanine of cysteine residues 110 and 187, components of a conserved disulfide bond in rhodopsin, affects the light-activated metarhodopsin II state, Proc. Natl Acad. Sci. USA 91, 40294033.
  • 26
    Noda, K., Saad, Y., Graham, R. M. & Karnik, S. S. (1994) The high affinity state of the β-2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines, J. Biol. Chem. 269, 67436752.
  • 27
    Savarese, T. M., Wang, C.-D. & Fraser, C. M. (1992) Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor, J. Biol. Chem. 267, 1143911448.
  • 28
    Lee, C., Gardella, T. J., Abou-Samra, A.-B., Nussbaum, S. R., Segre, G. V., Potts, J. T. Jr, Kronenberg, H. M. & Juppner, H. (1994) Role of the extracellular regions of parathyroid hormone (PTH)/PTH-related peptide receptor in hormone binding, Endocrinology 135, 14881495.